Laxative Recall Expanded Over Risk of Bacterial Infections

The laxative recall affects a number of store-brand products, including CVS, Walgreens, Kroger, Rite-Aid, Harris Teeter and Publix.

Following reports of bacterial infections associated with magnesium citrate laxative solutions, the manufacturer has expanded a prior recall to include all lots and flavors.

Vi-Jon, LLC initially issued the laxative recall in June, impacting lemon flavored products sold under more than 30 different store brand labels. However, in a statement posted by the FDA this week, the recall was expanded on July 25, impacting dozens of different flavors and product formulations.

The recalled laxatives now include cherry and grape flavors, as well as the lemon flavor originally recalled, including products sold under brand names like Best Choice, Care One, Chariba, CVS, Discount Drug Mart, Equaline, Equate, Exchange Select, Family Wellness, Good Sense, Harris Teeter, HEB, Health Mart, Kroger, Leader, Meijer, Premier Value, Publix, Quality Choice, Rexall, Rite Aid, Signature Care, Sunmark, Swan, Topcare, Up&Up and Walgreens.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Magnesium Citrate Saline Laxative Oral Solution is a product used to relieve occasional constipation and generally produces bowel movement in half an hour to six hours.

The laxative recall was first issued after third party testing identified the presence of Gluconacetobacter liquefaciens, a microbial contaminant. This is the second time the recall has been expanded. The original recall was limited to one lot of the product sold at CVS stores. Then the recall was expanded to include all lots of the lemon flavor, before this second expansion.

Consuming gluconacetobacter liquefaciens can increase a person’s risk of suffering bacterial infection. For patients who are immunocompromised, this can lead to serious, life-threatening adverse health consequences.

So far, at least three reports of serious adverse reactions have been linked to the recall. Vi-Jon is in the process of investigating those reports.

The products were packaged in a 10 oz clear round plastic bottle and sold in lemon, cherry and grape flavors, and distributed nationwide to wholesale and retail stores.

Vi-Jon is notifying its customers of the contamination and arranging for the return or destruction of all recalled products. Consumers who have the recalled product should stop using it immediately and return it to the place of purchase, even if there is some remaining product in the package.

Consumers can contact Vi-Jon with questions about the recall at or by visiting their website at

Adverse reactions or side effects experienced from using the product should be reported to the FDA’s MedWatch Adverse Event Reporting program.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024
Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024 (Posted yesterday)

With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.

Ozempic Gastroparesis Lawsuit Filed Over Failure To Warn About Permanent Stomach Problems
Ozempic Gastroparesis Lawsuit Filed Over Failure To Warn About Permanent Stomach Problems (Posted 3 days ago)

A South Dakota man has filed one of the first gastroparesis lawsuits against Ozempic manufacturers, alleging that users have not been adequately warned about the risk of severe vomiting and long-term stomach side effects.